Cancer News

New high-dose radiation therapy available for pediatric liver cancer patientsOct 4, 2018
A team of physician-scientists at Baylor College of Medicine and Texas Children’s Hospital are now using a new treatment option for pediatric patients with liver tumors, called Transarterial Radioembolization (TARE).
Grant supports research into racial, ethnic health disparitiesOct 3, 2018
The National Cancer Institute has awarded $6.3 million dollars Baylor researchers to create new tools to help researchers to better understand the biological causes behind racial and ethnic health disparities in prostate and breast cancers.
Math meets biology to uncover unexpected biorhythmsSep 19, 2018
A novel mathematical approach has uncovered that some animal cells have robust 12-hour cycles of genetic activity, in addition to circadian or 24-hour cycles.
Grant supports identifying leukemia, Down syndrome linkSep 18, 2018
To better understand a predisposition for acute lymphoblastic leukemia in children with Down syndrome, a team of researchers will sequence the genomes of more than 2,000 individuals with Down syndrome.
Breakthrough reveals mutation driving acute myeloid leukemiaSep 10, 2018
Researchers have discovered that the growth of leukemic cells depends on mutant NPM1 gene and its abnormal transport out of the nucleus into the cytoplasm of the cell.
Study: HPV cancer survivors at risk for second HPV cancerSep 7, 2018
A retrospective study found that survivors of HPV-associated cancers have a high incidence of developing second HPV-related cancers.
‘Homing system’ targets therapeutic T cells to brain cancerSep 5, 2018
A multi-institution international team led by researchers at Baylor College of Medicine has developed a new strategy to overcome one of the main obstacles in the treatment of brain cancer – access to the tumor. 
Research leads to rare ER+ breast cancer mutations insightSep 4, 2018
Researchers conducted the largest analysis to date to establish associations between rare somatic mutations and prognosis in estrogen receptor positive (ER+) breast cancer
New histiocytotic disorder insights may improve therapiesAug 30, 2018
In a review published in New England Journal of Medicine, physician-scientists review the history of Langerhans-cell histiocytosis (LCH) and the recent developments that will help propel the treatment for patients into the realm of personalized medicine.
Non-alcoholic fatty liver disease a risk factor for liver cancerAug 27, 2018
To establish a better understanding of the link between the risk for liver cancer and non-alcoholic fatty liver disease (NAFLD), researchers conducted a large, retrospective study of patients with and without NAFLD.